Suchergebnisse - "Giarratano, Tommaso"

PubPharm (32)

1

Gene-expression assays to tailor adjuvant endocrine therapy for HR+/HER2- breast cancer

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2024

von Bottosso, M. | Miglietta, F. | Vernaci, G. | +4

2

The Impact of COVID-19 on Treatment Practices for Patients With Early Breast Cancer : A Cross-Sectional Study From a Large Cancer Center in Italy

enthalten in: The oncologist | 2023

von Girardi, F. | Marini, S. | Porra, F. | +13

3

Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer : Analysis of four prospective studies

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Miglietta, F. | Dieci, M. | Giarratano, T. | +18

4

Characterization of Gut Microbiome Composition in Patients with Triple-Negative Breast Cancer Treated with Neoadjuvant Chemotherapy

enthalten in: The oncologist | 2023

von Vernaci, G. | Savarino, E. | Patuzzi, I. | +13

5

Platinum-based chemotherapy and PARP inhibitors for patients with a germline BRCA pathogenic variant and advanced breast cancer (LATER-BC) : retrospective multicentric analysis of post-progression treatments

enthalten in: European journal of cancer (Oxford, England : 1990) | 2023

von Valenza, C. | Trapani, D. | Gandini, S. | +15

6

HER2DX ERBB2 mRNA expression in advanced HER2-positive breast cancer treated with T-DM1

enthalten in: Journal of the National Cancer Institute | 2023

von Brasó-Maristany, F. | Griguolo, G. | Chic, N. | +24

CommentIn: J Natl Cancer Inst. 2023 Mar 9;115(3):242-245. - PMID 36576003

7

Optimizing CDK4/6 inhibitors in advanced HR+/HER2- breast cancer : A personalized approach

enthalten in: Critical reviews in oncology/hematology | 2022

von Fontanella, C. | Giorgi, C. | Russo, S. | +12

8

HER2-low-positive breast cancer : evolution from primary tumor to residual disease after neoadjuvant treatment

enthalten in: NPJ breast cancer | 2022

von Miglietta, F. | Griguolo, G. | Bottosso, M. | +12

9

Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer : Results of the Phase II GIADA Trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2022

von Dieci, M. | Guarneri, V. | Tosi, A. | +15

CommentOn: Clin Cancer Res. 2022 Jan 15;28(2):247. - PMID 35045957

10

Author Correction : Evolution of HER2-low expression from primary to recurrent breast cancer

enthalten in: NPJ breast cancer | 2021

von Miglietta, F. | Griguolo, G. | Bottosso, M. | +11

ErratumFor: NPJ Breast Cancer. 2021 Oct 12;7(1):137. - PMID 34642348